Risk factors and their association with mortality in patients undergoing long-term hemodialysis or/and kidney transplant patients or late-stage chronic kidney disease: A single center, prospective observational study
Yi Zhang,Minxiang Wu,Congbo Mao
DOI: https://doi.org/10.1097/md.0000000000036805
IF: 1.6
2024-01-11
Medicine
Abstract:Over the past decades, the burden of kidney diseases has increased, accounting for most health-related mortality cases, and morbidity concerns have spread globally. In line with this, the prevalence of cases of chronic renal disease has gradually increased over the years. Upon reaching the multiple critical stages of chronic kidney disease (CKD), a patient with this condition has a high risk of mortality before entering the final stage of CKD. Cardiovascular diseases (CVDs) are a very common occurrence in patients with CKD. [ 1 ] The presence of traditional risk factors, such as hypertension, dyslipidemia, and diabetes mellitus are responsible for mortality due to CVDs. In the new-world era, other nontraditional risk factors, such as inflammation and oxidative stress, significantly accelerate the prevalence of CVDs in patients with CKD. [ 2 ] Anomalies in lipid levels are generally observed in patients with CKD, and this condition is known as dyslipidemia, which is characterized by hypertriglyceridemia, a high level of very low-density lipoprotein cholesterol, with a decreased level of high-density lipoprotein cholesterol (HDL-C), while the low-density lipoprotein cholesterol concentration remains normal. In addition, an increased concentration of oxidants, to a greater extent due to inflammation and dialysis, in combination with malnutrition, markedly reduces the strength of the antioxidant defense system and can contribute to the oxidative stress environment in patients with CKD. Antioxidant enzymes, such as Paraoxonoase (PON)-1 related to HDL particles are more susceptible to alterations in an oxidative stress environment, [ 3 ] and their primary function is to protect the LDL particles against lipid oxidation. These antioxidant enzymes have 3 members, which comprise PON-1, PON-2, and PON-3; of these, PON-1 and PON-3 are found in humans, are predominantly produced in the liver and are mainly attached to the HDL-C in the circulation. The primary function of both enzymes is to regulate oxidative stress and inflammation to limit atherosclerosis in patients with kidney disease. There is evidence to indicate that the activity of PON-1 is reduced in patients with CKD. [ 4 ] However, to date, at least to the best of our knowledge, there are no data available on PON-3 in patients with CKD. Of note, malnutrition, inflammation, and oxidative stress can alter the redox status of lipoproteins in these patients. [ 5 ]
medicine, general & internal